Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Pfizer (Australia) GENTAMICIN 80 mg/2 mL (as sulfate) injection BP ampoule, Pfizer Australia Pty Ltd, CON-1029
Product name
Pfizer (Australia) GENTAMICIN 80 mg/2 mL (as sulfate) injection BP ampoule
Sponsor name
Pfizer Australia Pty Ltd
Consent start
Consent no.
CON-1029
Standard
Various sections of Therapeutic Goods Order No. 91 of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product has print direct stamped onto the plastic ampoules (TECA print) and
comply with the requirements of Therapeutic Goods Order No. 69 '“ General
Requirements for Labels for Medicines 2017 (TGO 69)
Therapeutic product type
Prescription medicines